{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:29:46Z","timestamp":1762867786048},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Eye Tumor Research Foundation"}],"content-domain":{"domain":["clinicalkey.fr","jaapos.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jaapos.2019.03.002","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T08:47:50Z","timestamp":1556354870000},"page":"241-243","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Heterochromia following intravitreal chemotherapy in two cases"],"prefix":"10.1016","volume":"23","author":[{"given":"David A.","family":"Camp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara E.","family":"Lally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2019.03.002_bib1","doi-asserted-by":"crossref","DOI":"10.1159\/000491432","article-title":"Precision intravitreal chemotherapy for localized vitreous seeding of retinoblastoma","author":"Yu","year":"2019","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.jaapos.2019.03.002_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for\u00a0vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2019.03.002_bib3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/IAE.0000000000000903","article-title":"Intravitreous chemotherapy for active vitreous seeding from retinoblastoma: outcomes after 192 consecutive injections. The 2015 Howard Naquin Lecture","volume":"36","author":"Shields","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.jaapos.2019.03.002_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3928\/01913913-20160719-04","article-title":"Retinoblastoma control with primary intra-arterial chemotherapy: outcomes before and during the intravitreal chemotherapy era","volume":"53","author":"Shields","year":"2016","journal-title":"J\u00a0Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.jaapos.2019.03.002_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10384-015-0378-0","article-title":"Intravitreal injection of melphalan for intraocular retinoblastoma","volume":"59","author":"Suzuki","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jaapos.2019.03.002_bib6","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jamaophthalmol.2015.3119","article-title":"Anterior ocular toxicity of intravitreous melphalan for retinoblastoma","volume":"133","author":"Francis","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jaapos.2019.03.002_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000453617","article-title":"Intracameral chemotherapy (melphalan) for aqueous seeding in retinoblastoma: bicameral injection technique and related toxicity in pilot case study","volume":"3","author":"Munier","year":"2017","journal-title":"Ocul Oncol Pathol"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853119300898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853119300898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T19:26:45Z","timestamp":1724873205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853119300898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1091853119300898"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2019.03.002","relation":{},"ISSN":["1091-8531"],"issn-type":[{"type":"print","value":"1091-8531"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterochromia following intravitreal chemotherapy in two cases","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2019.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}